Skip to main content
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.880
-0.010 (-0.53%)
At close: Apr 28, 2026, 4:00 PM EDT
1.880
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:42 PM EDT

Inhibikase Therapeutics Employees

Inhibikase Therapeutics had 35 employees as of December 31, 2025. The number of employees increased by 19 or 118.75% compared to the previous year.

Employees
35
Change (1Y)
19
Growth (1Y)
118.75%
Revenue / Employee
n/a
Profits / Employee
-$1,378,834
Market Cap
320.45M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20253519118.75%
Dec 31, 202416777.78%
Dec 31, 20239228.57%
Dec 31, 202270-
Dec 31, 202174133.33%
Dec 31, 2020 Pro Pro Pro

Related Stocks

Company Name Employees
Bicycle Therapeutics 288
Abeona Therapeutics 226
Cabaletta Bio 156
Nautilus Biotechnology 130
Foghorn Therapeutics 106
Rezolute 75
Surrozen 44
DiaMedica Therapeutics 35
Employee Rankings

IKT News

More News